Issuance of stock options as equity compensation
First written in FY2017-Q2. 5 of 8 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-10-08.
- FY2020ReframedAnnual report
「At the 19th Annual General Meeting of Shareholders held on 26 June 2019, the company resolved to introduce a restricted stock compensation plan for its directors, excluding outside directors, so that they would share the benefits and risks of share-price fluctuations with shareholders to a greater extent than before and strengthen their motivation to contribute to higher share prices and corporate value. At the same time, the company abolished its stock-based stock option plan for directors, excluding outside directors, and decided that, going forward, it would not make any new grants of share acquisition rights under the stock-based stock option plan for those directors, except for rights already allocated.」
While maintaining the policy of linking director compensation to the company's share price, we abolished new stock options with stock-based compensation and revised the system to provide restricted stock compensation. - FY2019-Q2AdvancedAnnual report
「① Details of the Stock Option Plan Date of resolution 5 July 2018 Category and number of persons eligible for grants Directors of the Company 18 Number of stock acquisition rights (units)* 463」
The company disclosed stock-based stock options for directors approved on 5 July 2018. A total of 463 options were granted to 18 people, representing 46,300 underlying shares, with an exercise period from 2 August 2018 through 1 August 2038. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: Series 11 Stock Acquisition Rights (stock-based compensation stock options).」
The company issued the 11th stock acquisition rights in the form of stock options as stock-based compensation for directors. The issue consists of 415 stock acquisition rights representing 41,500 underlying shares, with an exercise period from 2 September 2017 to 1 September 2037. - FY2017RestatedAnnual report
「⑩ Details of the stock acquisition rights issued on 1 September 2016 pursuant to a resolution of the company's Board of Directors held on 10 August 2016 10th Series of Stock Acquisition Rights (stock compensation-type stock options)」
The company disclosed that 433 stock options, representing 43,300 underlying shares, issued to directors in 2016 remain outstanding. - FY2017-Q2First statedAnnual report
「10th Stock Acquisition Rights (stock-compensation-type stock options)」
The company issued stock options in the form of share-based compensation for directors, comprising 433 stock acquisition rights and 43,300 underlying shares, with an exercise period from 2 September 2016 to 1 September 2046.